Sarikaya Ali, Top Husamettin, Aygit A Cemal, Benlier Erol, Unal Yasin
Department of Nuclear Medicine, Trakya University, Medical Faculty, Edirne, Turkey.
Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1500-7. doi: 10.1007/s00259-006-0120-8. Epub 2006 Jul 29.
Although various non-invasive procedures have been proposed to determine the optimal level of amputation of limbs in patients who have vascular disease, currently there are no consistent criteria that can be applied before surgery. The purpose of this study was to determine whether (99m)Tc-sestamibi imaging can accurately predict the healing of amputation sites.
In a prospective study in 26 patients (21 men, 5 women; age range 23-94 years) presenting with ulcers or gangrene of the foot and hand, (99m)Tc-sestamibi imaging was performed preoperatively. The indications for amputation included gangrene (23 patients), electrical injury (2 patients) and trauma (1 patient) of extremities. Although the amputation levels were chosen according to clinical criteria and scintigraphic results, the final amputation level was defined by scintigraphic results. Two below-knee, one above-knee, 12 toe, 11 transmetatarsal, two phalanx, one finger and one thumb amputations and one shoulder disarticulation were performed. In four cases, the amputation defect was not suitable for coverage using a local dermal flap; rather, it was covered with free tissue transfer. Patients had clinical follow-up for 6-36 months (mean 11.69 months) to assess healing of the stump. Scan results were compared with clinical outcome to assess prediction of healing.
There was healing in all amputations at the end of the follow-up period. When evaluated regarding preoperative (99m)Tc-sestamibi uptake pattern, there was no perfusion to the lesion site in 21 patients and perfusion to an area smaller than the extent of skin necrosis in four patients; thus, in these 25 patients, (99m)Tc-sestamibi scintigraphy suggested non-viable tissue in the extremities with clear-cut edges of perfused muscle tissue. Diffusely decreased uptake was seen below the left knee in one case. How scintigraphy changed management was analysed. The amputation levels proposed before scintigraphy were divided into two groups, "definite" (n=14) and "indefinite" (n=12), based on visual examination and Doppler findings. In nine patients in the definite group, the proposed amputation level before scintigraphy was not altered by the scintigraphic data. However, (99m)Tc-sestamibi scan enabled unnecessarily high amputation levels to be avoided in 12 patients in the indefinite group and in five patients in the definite group. Therefore, there was change in management of 65% of cases based on scintigraphic findings.
Since healing of the stump was seen in all cases, outcome was correctly predicted by scintigraphy. This preliminary study supports the use of (99m)Tc-sestamibi scan in selecting the optimal amputation level consistent with subsequent stump healing.
尽管已提出多种非侵入性方法来确定血管疾病患者肢体的最佳截肢水平,但目前尚无术前可应用的统一标准。本研究的目的是确定锝-99m(99mTc)-甲氧基异丁基异腈显像能否准确预测截肢部位的愈合情况。
对26例(21例男性,5例女性;年龄范围23 - 94岁)足部或手部出现溃疡或坏疽的患者进行前瞻性研究,术前进行99mTc-甲氧基异丁基异腈显像。截肢指征包括肢体坏疽(23例)、电击伤(2例)和创伤(1例)。尽管截肢水平根据临床标准和闪烁显像结果选择,但最终截肢水平由闪烁显像结果确定。进行了2例膝下截肢、1例膝上截肢、12例截趾、11例经跖骨截肢、2例指骨截肢、1例手指截肢、1例拇指截肢和1例肩关节离断术。4例患者的截肢缺损不适合用局部皮瓣覆盖,而是采用游离组织移植覆盖。对患者进行了6 - 36个月(平均11.69个月)的临床随访,以评估残端愈合情况。将扫描结果与临床结果进行比较,以评估愈合预测情况。
随访期结束时所有截肢部位均愈合。根据术前99mTc-甲氧基异丁基异腈摄取模式评估,21例患者病变部位无灌注,4例患者灌注区域小于皮肤坏死范围;因此,在这25例患者中,99mTc-甲氧基异丁基异腈闪烁显像提示肢体中存在无活力组织,灌注肌肉组织边缘清晰。1例患者左膝以下可见弥漫性摄取降低。分析了闪烁显像如何改变治疗方案。根据视觉检查和多普勒检查结果,将闪烁显像前建议的截肢水平分为两组,“确定”组(n = 14)和“不确定”组(n = 12)。在确定组的9例患者中,闪烁显像数据未改变闪烁显像前建议的截肢水平。然而,99mTc-甲氧基异丁基异腈扫描使不确定组的12例患者和确定组的5例患者避免了不必要的高位截肢。因此,65%的病例治疗方案根据闪烁显像结果发生了改变。
由于所有病例残端均愈合,闪烁显像正确预测了结果。这项初步研究支持在选择与后续残端愈合一致的最佳截肢水平时使用99mTc-甲氧基异丁基异腈扫描。